STRATA Skin Sciences, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues, net
Cost of revenues
Gross profit
Operating expenses:
Engineering and product development
Selling and marketing
General and administrative
Total operating expenses
Impairment of goodwill
Settlement gains

Total operating expenses
Loss from operations
Interest expense
Interest expense
Interest income
Loss on debt extinguishment
Other income
Other (expense), income net
Loss before (provision for) benefit from income taxes
(Provision for) benefit from income taxes
Net loss
Common Shares
Convertible Preferred Stock Series C
Total net loss

Net loss per share of common stock - basic (in Dollars per share)
Common Shares
Convertible Preferred Stock Series C
Total net loss per share of common stock - basic (in Dollars per share)

Net loss per share of common stock - diluted (in Dollars per share)
Common Shares
Convertible Preferred Stock Series C
Total net loss per share of common stock - diluted (in Dollars per share)

Weighted average shares of common stock outstanding - basic (in Shares)
Common Shares
Convertible Preferred Stock Series C
Total weighted average shares of common stock outstanding - basic (in Shares)

Weighted average shares of common stock outstanding - diluted (in Shares)
Common Shares
Convertible Preferred Stock Series C
Total weighted average shares of common stock outstanding - diluted (in Shares)

Comments